Periodontal disease is a chronic inflammatory disease that is largely attributable to infections with gram-negative bacteria and is characterised by both gingival inflammation and alveolar bone resorption. Beside macrophages, the second most common cells of the gingival inflammatory infiltrat are mast cells. Mast cells are heterogenous cell population which live from six months to one year. These cells are activated by differnt immunologic and non-immunologic signals. Activated mast cells can secrete a range of substances that regulate angiogenesis, tissue remodeling and wound healing, which include both degradation and synthesis of tissue components. Apart from that, mast cells have an important role in phagocytosis, antigen processing and presentation to T-cells. It is confirmed that gingival mast cells can express matrix metalloproteinases (MMPs) and the tissue inhibitors of metalloproteinases, TIMP-1 and TIMP-2. This indicates that mast cells are likely to play an important role in inflammation and tissue degradation in periodontal diseases.
Batista AC, Rodini CO, Lara VS. Quantification of mast cells in different stages of human periodontal disease. Oral Diseases. 11(4):249–54.
2.
Malaviya R, Ross E, Jakschik BA, Abraham SN. Mast cell degranulation induced by type 1 fimbriated Escherichia coli in mice. J Clin Invest. 93:1645–53.
3.
Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature. 381:77–80.
4.
Malaviya R, Abraham SN. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. J Leukoc Biol. 67:841–6.
5.
Carranza FAJ, Cabrini RL. Mast cells in human gingiva. Oral Surg. 8:109–39.
6.
Shapiro S, Ulmansky M, Scheuer M. Mast cell population in gingivae affected by chronic destructive periodontal disease. Periodontics. 40:27–68.
7.
Robinson LP, Marco TJ. Alteration of mast cell densities in experimentally inflamed human gingivae. J Periodontol. 43:614–22.
8.
Walsh LJ, Davis MF, Xu LJ, Savage NW. Relationship between mast cell degranulation and inflammation in the oral cavity. J Oral Pathol Med. 24:266–72.
9.
Lin TJ, Befus AD. Mast cells and eosinophils in mucosal defenses and pathogenesis. In: Mucosal Immunology. p. 1999 469-82.
10.
Steinsvoll S, Halstensen TS, Schenck K. Extensive expression of TGF-beta1 in chronically-inflamed periodontal tissue. J Clin Periodontol. 26:366–73.
11.
Dewar MR. Mast cells in gingival tissue. J Periodont. 29:67–70.
12.
Shapiro S, Ulmansky M, Scheuer M. Mast cell population in gingivae affected by chronic destructive periodontal disease. Periodontics. 40:27–68.
13.
Zachrisson BV. Mast cells of the human gingiva. IV Experimental gingivitis J Periodont Res. 4:465–55.
14.
Kennett CN, Cox SW, Eley BM, Osman IA. Comparative histochemical and biochemical studies of mast cell tryptase in human gingival. J Periodontol. 64:870–7.
15.
Malaviya R, Twesten NJ, Ross EA, Abraham SN, Pfeifer JD. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J Immunol. 156:1490–6.
16.
Marjanović D. Analiza zastupljenosti glikogena i mastocita u gingivi bolesnika sa parodontopatijom. Магистарска теза, Косовска Митровица.
17.
Carranza FAJ, Cabrini RL. Mast cells in human gingiva. Oral Surg. 8:109–39.
18.
Zachrisson BV. Mast cells of the human gingiva. II. Metachromatic cells at low pH in healthy and inflamed tissue. J Periodont Res. 2:87–105.
19.
Shelton LE, Hall WB. Human gingival Mast cells. Effects of chronic inflammation J Periodont Res. 2:214–23.
20.
Robinson LP, Marco TJ. Alteration of mast cell densities in experimentally inflamed human gingivae. J Periodontol. 43:614–22.
21.
Gemmell E, Carter CL, Seymour GJ. Mast cells in human periodontal disease. J Dent Res. 83:38–47.
22.
Walls AF, Jones DB, Williams JH, Church MK, Holgate ST. Immunohistochemical identification of mast cells in formaldehyde-fixed tissue using monoclonal antibodies specific for tryptase. J Pathol. 162:119–26.
23.
Naesse EP, Schreurs O, Helgeland K, Schenck K, Steinsvoll S. Matrix metalloproteinases and their inhibitors in gingival mast cells in persons with and without HIV-infection. J Periodont Res. 38:575–82.
24.
Girolama N, D W. In vitro and in vivo expression of interstitial collagenase/MMP-1 by human mast cells. Dev Immunol. 7:131–42.
25.
Johnson JL, Jackson CL, Angelini GD, George SJ. Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 18:1707–15.
26.
Martignetti JA, Aqeel AA, Sewairi WA, Boumah CE, Kambouris M, SA M, et al. Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat Genet. 28:261–5.
27.
Wielockx B, Lannoy K, Shapiro SD, Itoh T, Itohara S, Vandekerckhove J, et al. Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy. Nat Med. 8:179–84.
Page RC, Schroeder HE. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest. 34:235–49.
30.
Sur R, Cavender D, Malaviya R. Different approaches to study mast cell functions. Inter Immunopharmacol. 7(5):555–67.
31.
Echtenacher B, Mannel DN, Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature. 381(757).
32.
Abraham SN, Malaviya R. Mast cell modulation of the innate immune response to enterobacterial infection. Adv Exp Med Biol. 479:91–105.
33.
Nilsson G, Metcalfe DD. Contemporary issues in mast cell biology. Allergy Asthma Proc. 17:59–63.
34.
Abraham SN, Arock M. Mast cells and basophils in innate immunity. Semin Immunol. 10:373–81.
35.
Galli SJ. Mast cells and basophils. Curr Opin Hematol. 7:32–9.
36.
Steinsvoll S, Helgeland K, Schenck K. Mast cells a role in periodontal diseases? J Clin Periodontol. 31(6):413–9.
37.
Irani AM, Goldstein SM, Wintroub BU, Bradford T, Schwartz LB. Human mast cells carboxypeptidase. Selective localization to MCTC cells. J Immunol. 147:247–53.
38.
Irani AM, Bradford TR, Kepley CL, Schechter NM, Schwartz LB. Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem. 37:1509–15.
39.
Weidner N, Austen KF. Heterogeneity of mast cells at multiple body sites. Fluorescent determination of avidin binding and immunofluorescent determination of chymase, tryptase, and carboxypeptidase content. Pathol Res Pract. 189:156–62.
40.
Malaviya R, Abraham SN. Clinical implications of mast cell-bacteria interaction. J Mol Med. 76:617–23.
41.
Henz BM, Maurer M, Lippert U, Worm M, Babina M. Mast cells as initiators of immunity and host defense. Exp Dermatol. 10(110).
42.
Williams DM, Hughes FJ, Odell EW, Farthing PM. Pathology of Periodontal Disease.
43.
Gilfillan AM, Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat Rev Immunol. 6:218–30.
44.
Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune response. Nat Immunol. 6:135–42.
45.
Marshall JS. Mast-cell responses to pathogens. Nat Rev Immunol. 4:787–99.
46.
Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as “tunable” effector and immunoregulatory cells: recent advances. Annu Rev Immunol. 23:749–86.
47.
Metz M, Piliponsky AM, Chen CC, Lammel V, Abrink M, Pejler G, et al. Mast cells can enhance resistance to snake and honeybee venoms. Science. 313:526–30.
48.
Grimbaldeston MA, Metz M, Yu M, Tsai M, Galli SJ. Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses. Curr Opin Immunol. 18:751–60.
49.
Maurer M, Theoharides T, Granstein RD, Bischoff SC, Bienenstock J, B H, et al. What is the physiological function of mast cells? Ex Dermatol. 12:886–910.
50.
Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 4:197–250.
51.
Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem. 378:151–60.
52.
Parsons SL, Watson SA, Brown PD, Collins HM, Steele RJ. Matrix metalloproteinases. Brit J Surg. 84:160–6.
53.
McCawley LJ, Matrisian LM. Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today. 6:149–56.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
